Join the Fight Against MDS

Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.

Viewing: Patient & VisitorPatient & Visitor HCPHealthcare Professional

May 7, 2025

The 18^thInternational Congress on MDS

The 18th International Congress on Myelodysplastic Syndromes (MDS 2025) took place from 7-10 May 2025 in Rotterdam, Netherlands.

Participants joined the premier forum for the latest advancements in myelodysplastic syndromes, where international MDS experts and peers dove into the most recent discoveries, basic and translational research, and MDS diagnosis, prognosis, and management.

They benefited from high-level research and science while getting the chance to meet the global MDS community.
Together, they enhanced knowledge, established collaborations, and moved the field forward.

Co-Chairs

Saskia M.C. Langemeijer, MD

Arjan van de Loosdrecht, MD, PhD

Theo de Witte, MD, PhD

Presentation Recordings

Access to the meeting presentations are available below by clicking on each topic.

Join the Fight Against MDS

The 18^thInternational Congress on MDS

Co-Chairs

Presentation Recordings

Workshop - MDS Treatment (Part 1)

Workshop - MDS Treatment (Part 2)

Opening Ceremony & Keynote Lecture

Plenary Session 1: Molecular Pathogenesis of MDS

Plenary Session 2: Immunology and Microenvironment in MDS

MDS Lifetime Achievement Awards

BMS-Sponsored Session: Reimagining Care in Lower-Risk MDS

Rapid Fire Session 1: Two-min Abstract Presentations

Plenary Session 3: Clonal Hematopoiesis and VEXAS

Collaborative Debate Session: Therapeutic Agents in MDS - Too Few and not Effective Enough

Plenary Session 4: Integrated MDS Diagnostics in 2025

Plenary Session 5: MDS Classification in 2025

Rapid Fire Session 2: Two-min Abstract Presentations

Plenary Session 6: Treatment Low Risk MDS (Part 1)

EHA and MDS Foundation Joint Session

Plenary Session 7: Treatment Low Risk MDS (Part 2)

Plenary Session 8: Treatment High Risk

Keynote Lecture

The Tito Bastianello and MDSF Young Investigator Grant Awards and Closing Remarks

Get in touch

Join the Fight Against MDS

The 18th International Congress on MDS

Co-Chairs

Presentation Recordings

Workshop - MDS Treatment (Part 1)Eva Hellstrom-Lindberg, MD, PhDAmy Elizabeth DeZern, MD, MHS

Workshop - MDS Treatment (Part 1)

Workshop - MDS Treatment (Part 2)Valeria Santini, MDMoshe Mittelman, MD

Workshop - MDS Treatment (Part 2)

Opening Ceremony & Keynote LectureArjan van de Loosdrecht, MD, PhDSaskia M.C. Langemeijer, MDStephen D. Nimer, MDPeggy Ann TorneyMatteo Giovanni Della Porta, MD

Opening Ceremony & Keynote Lecture

Plenary Session 1: Molecular Pathogenesis of MDSSeishi OgawaPedro MouraColeman LindsleyOnima ChowdhuryStephani Schmitz

Plenary Session 1: Molecular Pathogenesis of MDS

Plenary Session 2: Immunology and Microenvironment in MDSMarc H.C. RaaijmakersDaniel StarczynowskiAmit Verma, MDAditi Shastri, MDWillemijn Hobo

Plenary Session 2: Immunology and Microenvironment in MDS

MDS Lifetime Achievement AwardsStephen D. Nimer, MDJohn M. BennettPeter L. Greenberg, MD

MDS Lifetime Achievement Awards

BMS-Sponsored Session: Reimagining Care in Lower-Risk MDSMatteo Giovanni Della Porta, MDAmer Zeidan, MDThomas Cluzeau

BMS-Sponsored Session: Reimagining Care in Lower-Risk MDS

Rapid Fire Session 1: Two-min Abstract PresentationsLorea Chaparro-GonzálezTony RachedFuhui LiJoão Vitor C. GoesSvilena A. AtanasovaJulia MestreLuca Guarnera

Rapid Fire Session 1: Two-min Abstract Presentations

Plenary Session 3: Clonal Hematopoiesis and VEXASJoop JansenSusann WinterDavid BeckBabal K. JhaRonald F. Pinheiro

Plenary Session 3: Clonal Hematopoiesis and VEXAS

Collaborative Debate Session: Therapeutic Agents in MDS - Too Few and not Effective EnoughMoshe Mittelman, MDAmer Zeidan, MDDavid P. Steensma, MD, FACP

Collaborative Debate Session: Therapeutic Agents in MDS - Too Few and not Effective Enough

Plenary Session 4: Integrated MDS Diagnostics in 2025Sanam LoghaviArjan van de Loosdrecht, MD, PhDElsa Bernard, PhDAline AywazJulia Mestre

Plenary Session 4: Integrated MDS Diagnostics in 2025

Plenary Session 5: MDS Classification in 2025Ulrich Germing, MDRobert P. HasserjianAmer Zeidan, MDEric J. Duncavage, MDXin Wang

Plenary Session 5: MDS Classification in 2025

Rapid Fire Session 2: Two-min Abstract PresentationsChen MeiXin WangRoi GatChenmeng LiuCatharina MundtVikas SharmaGregorio Maria BergonziAraceli Sama Barroso

Rapid Fire Session 2: Two-min Abstract Presentations

Plenary Session 6: Treatment Low Risk MDS (Part 1)Hege K. Gravdahl GareliusMaria Diez-Campelo, MD, PhDPierre Fenaux, MD, PhDCarlos Ruiz ArenasMarco G. Raddi

Plenary Session 6: Treatment Low Risk MDS (Part 1)

EHA and MDS Foundation Joint SessionKirsten Gronbaek, MDMichael R. Savona, MD

EHA and MDS Foundation Joint Session

Plenary Session 7: Treatment Low Risk MDS (Part 2)Valeria Santini, MDMikkael Sekeres, MD, MSNicolaus Kroger, MD, PhDManja WobusThibault Comont

Plenary Session 7: Treatment Low Risk MDS (Part 2)

Plenary Session 8: Treatment High RiskLionel Adès, MD, PhDDavid A. Sallman, MDBart L. Scott, MDDespoina DimitriouAmer Zeidan, MD

Plenary Session 8: Treatment High Risk

Keynote LectureGuillermo Garcia-Manero, MD

Keynote Lecture

The Tito Bastianello and MDSF Young Investigator Grant Awards and Closing RemarksKatharina S. Gotze, MDStephen D. Nimer, MDSydney Lu, MD, PhDLin-Pierre Zhao, MD, PhDSaskia M.C. Langemeijer, MDArjan van de Loosdrecht, MD, PhDMaiko SezaklLuca L. JanssenKarin D. Prummel

The Tito Bastianello and MDSF Young Investigator Grant Awards and Closing Remarks

Get in touch

The 18^thInternational Congress on MDS